Video #503  

Indoor Biotechnologies

Indoor Biotechnologies


About Us

Biotechnology company specializing in manufacturing innovative products for investigating environmental and immunologic aspects of asthma and allergic diseases. Indoor Biotechnologies is an immunodiagnostics and biotechnology company specializing in manufacturing innovative products for investigating allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens. The company is at the forefront of research on allergen structure, molecular biology and immune response. Our mission is to improve the quality of life of patients with allergy and asthma. Indoor Biotechnologies is privately held and organized as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas. IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand. Indoor Biotechnologies has a global presence, with authorized distributors in Japan, China, South Korea, Australia and New Zealand and sales in 35 different countries. Indoor Biotechnologies is an entrepreneurial company that couples innovative science with a creative approach to business to add value through technology. Indoor Biotechnologies core technology is a comprehensive, proprietary portfolio of antibodies for the detection of house dust mite, cat, dog, cockroach, mold, pollen and food allergens. These antibodies are key components in assay platforms including ELISA and MARIA technology for allergen detection and our Ventia rapid allergen test. Indoor Biotechnologies has a complete range of tests for assessing environmental exposure to indoor allergens; for testing the efficacy of allergen avoidance procedures, products and devices, for allergen standardization and for new product development. Indoor Biotechnologies also manufactures purified natural and recombinant allergens for research use and for development of allergy diagnostics and vaccines. This product line currently includes fifty purified allergens that are manufactured to a high degree of purity and biologic activity. The line includes purified LoTox allergens with low endotoxin content that are designed for immunologic studies of allergy and asthma.